153 related articles for article (PubMed ID: 30948772)
1. Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells.
Lundberg M; Mattsson Å; Reiser K; Holmgren A; Curbo S
Sci Rep; 2019 Apr; 9(1):5656. PubMed ID: 30948772
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
[TBL] [Abstract][Full Text] [Related]
3. Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.
Azimi I; Matthias LJ; Center RJ; Wong JW; Hogg PJ
J Biol Chem; 2010 Dec; 285(51):40072-80. PubMed ID: 20943653
[TBL] [Abstract][Full Text] [Related]
4. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
Reiser K; Mathys L; Curbo S; Pannecouque C; Noppen S; Liekens S; Engman L; Lundberg M; Balzarini J; Karlsson A
PLoS One; 2016; 11(1):e0147773. PubMed ID: 26816344
[TBL] [Abstract][Full Text] [Related]
5. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
[TBL] [Abstract][Full Text] [Related]
6. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
[TBL] [Abstract][Full Text] [Related]
7. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
8. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides.
Kirkpatrick DL; Kuperus M; Dowdeswell M; Potier N; Donald LJ; Kunkel M; Berggren M; Angulo M; Powis G
Biochem Pharmacol; 1998 Apr; 55(7):987-94. PubMed ID: 9605422
[TBL] [Abstract][Full Text] [Related]
10. Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo.
Lin QD; Liu LN; Liu XY; Yan Y; Fang BJ; Zhang YL; Zhou J; Li YF; Zuo WL; Song YP
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1283-1292. PubMed ID: 35253185
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.
Reynoso E; Liu H; Li L; Yuan AL; Chen S; Wang Z
J Biol Chem; 2017 Oct; 292(42):17514-17524. PubMed ID: 28878015
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry.
Moolla N; Killick M; Papathanasopoulos M; Capovilla A
Biochim Biophys Acta; 2016 Sep; 1860(9):1854-63. PubMed ID: 27233453
[TBL] [Abstract][Full Text] [Related]
14. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control.
Owen GR; Le D; Stoychev S; Cerutti NM; Papathanasopoulos M
Biochem Biophys Res Commun; 2018 Mar; 497(2):811-817. PubMed ID: 29470989
[TBL] [Abstract][Full Text] [Related]
15. Redox control on the cell surface: implications for HIV-1 entry.
Matthias LJ; Hogg PJ
Antioxid Redox Signal; 2003 Feb; 5(1):133-8. PubMed ID: 12626125
[TBL] [Abstract][Full Text] [Related]
16. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
Barbouche R; Miquelis R; Jones IM; Fenouillet E
J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
[TBL] [Abstract][Full Text] [Related]
17. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
18. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.
Furci L; Sironi F; Tolazzi M; Vassena L; Lusso P
Blood; 2007 Apr; 109(7):2928-35. PubMed ID: 17132727
[TBL] [Abstract][Full Text] [Related]
19. The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.
Jordan BF; Runquist M; Raghunand N; Gillies RJ; Tate WR; Powis G; Baker AF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):529-36. PubMed ID: 15701837
[TBL] [Abstract][Full Text] [Related]
20. Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analogues.
Oblong JE; Chantler EL; Gallegos A; Kirkpatrick DL; Chen T; Marshall N; Powis G
Cancer Chemother Pharmacol; 1994; 34(5):434-8. PubMed ID: 8070012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]